213 related articles for article (PubMed ID: 25311280)
21. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
[TBL] [Abstract][Full Text] [Related]
22. Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry.
Shi J; Stonnington CM; Thompson PM; Chen K; Gutman B; Reschke C; Baxter LC; Reiman EM; Caselli RJ; Wang Y;
Neuroimage; 2015 Jan; 104():1-20. PubMed ID: 25285374
[TBL] [Abstract][Full Text] [Related]
23. Brain-Cognition Associations in Older Patients With Remitted Major Depressive Disorder or Mild Cognitive Impairment: A Multivariate Analysis of Gray and White Matter Integrity.
Marawi T; Zhukovsky P; Rashidi-Ranjbar N; Bowie CR; Brooks H; Fischer CE; Flint AJ; Herrmann N; Mah L; Pollock BG; Rajji TK; Tartaglia MC; Voineskos AN; Mulsant BH;
Biol Psychiatry; 2023 Dec; 94(12):913-923. PubMed ID: 37271418
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
25. White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Coutu JP; Goldblatt A; Rosas HD; Salat DH;
J Alzheimers Dis; 2016; 49(2):329-42. PubMed ID: 26444767
[TBL] [Abstract][Full Text] [Related]
26. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
27. Reproducibility of Brain Volume Changes in Longitudinal Voxel-Based Morphometry Between Non-Accelerated and Accelerated Magnetic Resonance Imaging.
Takao H; Amemiya S; Abe O;
J Alzheimers Dis; 2021; 83(1):281-290. PubMed ID: 34308908
[TBL] [Abstract][Full Text] [Related]
28. Coupling Between Hippocampal Parenchymal Fraction and Cortical Grey Matter Atrophy at Different Stages of Cognitive Decline.
Xiao Y; Liao L; Huang K; Yao S; Gao L;
J Alzheimers Dis; 2023; 93(2):791-801. PubMed ID: 37092228
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal pattern of regional brain volume change differentiates normal aging from MCI.
Driscoll I; Davatzikos C; An Y; Wu X; Shen D; Kraut M; Resnick SM
Neurology; 2009 Jun; 72(22):1906-13. PubMed ID: 19487648
[TBL] [Abstract][Full Text] [Related]
30. Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease.
Dicks E; van der Flier WM; Scheltens P; Barkhof F; Tijms BM;
Neurobiol Aging; 2020 Oct; 94():71-80. PubMed ID: 32585492
[TBL] [Abstract][Full Text] [Related]
31. Mapping Dynamic Changes in Ventricular Volume onto Baseline Cortical Surfaces in Normal Aging, MCI, and Alzheimer's Disease.
Madsen SK; Gutman BA; Joshi SH; Toga AW; Jack CR; Weiner MW; Thompson PM
Multimodal Brain Image Anal (2013); 2013; 8159():84-94. PubMed ID: 25152934
[TBL] [Abstract][Full Text] [Related]
32. Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.
Brendel M; Sauerbeck J; Greven S; Kotz S; Scheiwein F; Blautzik J; Delker A; Pogarell O; Ishii K; Bartenstein P; Rominger A;
J Alzheimers Dis; 2018; 65(3):793-806. PubMed ID: 30010116
[TBL] [Abstract][Full Text] [Related]
33. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
[TBL] [Abstract][Full Text] [Related]
34. Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment.
Thambisetty M; An Y; Kinsey A; Koka D; Saleem M; Güntert A; Kraut M; Ferrucci L; Davatzikos C; Lovestone S; Resnick SM
Neuroimage; 2012 Jan; 59(1):212-7. PubMed ID: 21824521
[TBL] [Abstract][Full Text] [Related]
35. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
Hagemeier J; Woodward MR; Rafique UA; Amrutkar CV; Bergsland N; Dwyer MG; Benedict R; Zivadinov R; Szigeti K
Psychiatry Res Neuroimaging; 2016 Sep; 255():87-93. PubMed ID: 27567325
[TBL] [Abstract][Full Text] [Related]
36. Callosal thickness profiles for prognosticating conversion from mild cognitive impairment to Alzheimer's disease: A classification approach.
Adamson C; Beare R; Ball G; Walterfang M; Seal M;
Brain Behav; 2018 Dec; 8(12):e01142. PubMed ID: 30565884
[TBL] [Abstract][Full Text] [Related]
37. Integrated cortical structural marker for Alzheimer's disease.
Ming J; Harms MP; Morris JC; Beg MF; Wang L
Neurobiol Aging; 2015 Jan; 36 Suppl 1():S53-9. PubMed ID: 25444604
[TBL] [Abstract][Full Text] [Related]
38. Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.
Knopman DS; Jack CR; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
Neurobiol Aging; 2016 Oct; 46():32-42. PubMed ID: 27460147
[TBL] [Abstract][Full Text] [Related]
39. Profiling heterogeneity of Alzheimer's disease using white-matter impairment factors.
Sui X; Rajapakse JC;
Neuroimage Clin; 2018; 20():1222-1232. PubMed ID: 30412925
[TBL] [Abstract][Full Text] [Related]
40. Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment.
Westman E; Aguilar C; Muehlboeck JS; Simmons A
Brain Topogr; 2013 Jan; 26(1):9-23. PubMed ID: 22890700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
